
Giovanni Marchegiani/X
Feb 14, 2025, 10:23
Giovanni Marchegiani: Prognostic factors in resected pancreatic cancer
Giovanni Marchegiani, Academic surgeon at Padova University Hospital, shared an article Ammar A Javed and colleagues authored on X:
“Prognostic factors in resected pancreatic cancer: personalized model according to neoadjuvant chemo
2.7k PDAC / 20% after NAT
NAT negative predictors are non normalized CA 19.9 / N+/ grade treatment response.”
Authors: Ammar A Javed et al.
Ammar A. Javed
Asad Fatimi
Bas Groot Koerkam
Brady A. Campbell
Camila Hidalgo Salinas
cancer
Christopher L. Wolfgang
Giovanni Marchegiani
Hjalmar C. van Santvoort
I Quintus Molenaar
Ingmar F. Rompen
Iris W.J.M. van Goor
Jin He
Joseph R. Habib
Lois A Daamen
Mahmud Omar
Marc G Besselink
OncoDaily
Oncology
Pancreatic Cancer
Paul C.M. Andel
Thijs J. Schouten
Thomas F. Stoop
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 19, 2025, 02:55
Feb 19, 2025, 02:42
Feb 18, 2025, 19:27
Feb 18, 2025, 19:12
Feb 18, 2025, 19:03
Feb 18, 2025, 18:55
Feb 18, 2025, 18:13
Feb 18, 2025, 17:57